Proteins / NOMO3
NOMO3
Nodal modulator 3
Predicted 3D structure
AlphaFold model.
In plain language
NOMO3 has barely been studied. The model's best guess: A large, secreted and membrane-proximal scaffold that assembles multiple beta-sandwich and transthyretin-like modules to create high-avidity binding surfaces. By organizing extracellular and membrane-associated complexes, it modulates developmental signaling circuits and likely dampens Notch pathway activity.
A large, secreted and membrane-proximal scaffold that assembles multiple beta-sandwich and transthyretin-like modules to create high-avidity binding surfaces.
Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.
Protein domains
Known building blocks found by InterPro, placed along the 1222 amino acids of the chain. Hover or tap a block for details.
- Immunoglobulin-like fold · 122–226
- Carbohydrate-binding-like fold · 127–202
- Carbohydrate-binding-like fold · 329–403
- Carbohydrate-binding-like fold · 883–954
- Carboxypeptidase-like, regulatory domain superfamily · 964–1053
- NOMO-like, N-terminal beta-sandwich domain · 40–124
- NOMO, third transthyretin-like domain · 226–325
- NOMO, fifth transthyretin-like domain · 409–498
- NOMO, seventh transthyretin-like domain · 592–664
- NOMO, eighth prealbumin-like domain · 746–798
- NOMO-like, ninth beta-sandwich domain · 799–873
- SpaA-like, prealbumin fold domain subgroup 1 · 874–955
- NOMO, C-terminal transthyretin-like domain · 1054–1147
- Serine-Aspartate Repeat-Containing · 44–1191
Predicted function
Model summary
A large, secreted and membrane-proximal scaffold that assembles multiple beta-sandwich and transthyretin-like modules to create high-avidity binding surfaces. By organizing extracellular and membrane-associated complexes, it modulates developmental signaling circuits and likely dampens Notch pathway activity. Its multivalent architecture supports broad protein interactions and transient ribosome association near the cell surface, coupling co-translational handling of secretory clients to the attenuation of receptor–ligand signaling.
Predicted Gene Ontology terms
Biological process
Which larger process it takes part in
- GO:0045746 negative regulation of Notch signaling pathway
Model reasoning
How the model got to its answer
- 01
I begin by dissecting the InterPro architecture and its order along the polypeptide.
The N-terminus carries IPR055075 (NOMO-like, N-terminal beta-sandwich domain, residues 40–124), immediately followed by an extensive beta-sandwich/Ig-like core: IPR013783 (Immunoglobulin-like fold, residues 122–226) overlaps this region and continues into IPR056189 (NOMO, third transthyretin-like domain, residues 226–325). Mid-chain, there is a second transthyretin/prealbumin-like block: IPR013784 (Carbohydrate-binding-like fold, residues 127–202) overlaps the N-terminal Ig-like region and reinforces a beta-sandwich scaffold; a later carbohydrate-binding-like module appears again (IPR013784, residues 329–403), and this is followed by IPR056190 (NOMO, fifth transthyretin-like domain, residues 409–498). The central-to-distal region continues a series of NOMO-specific transthyretin/prealbumin-like domains—IPR056319 (NOMO, seventh transthyretin-like domain, residues 592–664), IPR056187 (NOMO, eighth prealbumin-like domain, residues 746–798), and IPR055073 (NOMO-like, ninth beta-sandwich domain, residues 799–873)—culminating in a C-terminal module that is characteristic of secreted beta-sandwich proteins: IPR041033 (SpaA-like, prealbumin fold domain subgroup 1, residues 874–955) and IPR013784 (Carbohydrate-binding-like fold, residues 883–954). Immediately downstream sits IPR008969 (Carboxypeptidase-like, regulatory domain superfamily, residues 964–1053), a non-catalytic regulatory fold often used for ligand or partner recognition. The extreme C-terminus is completed by IPR056191 (NOMO, C-terminal transthyretin-like domain, residues 1054–1147). The entire chain is encompassed by IPR051417 (Serine-Aspartate Repeat-Containing family, residues 44–1191), indicating an extended repeat-rich scaffold that favors multivalent binding.
- 02
This ordered array of beta-sandwich and transthyretin/prealbumin-like domains creates a modular, secreted scaffold optimized for avid, multivalent interactions rather than catalysis.
The repeated NOMO/transthyretin-like modules and Ig-like fold collectively generate broad protein-binding surfaces, directly supporting GO:0005515 protein binding as a core molecular function. The presence of ribosome-engaging beta-sandwich modules and the overall secretory/surface-exposed architecture rationalize GO:0043022 ribosome binding: secreted and membrane-proximal scaffolds can transiently associate with ribosomes at the ER or cell surface to coordinate translation-coupled secretion and to chaperone client proteins.
- 03
From these binding capabilities, I infer a role in signaling modulation.
The multivalent scaffold can sequester or present ligands and receptors, thereby tuning pathway flux. This architecture naturally explains negative control of a juxtacrine signaling axis: by binding and stabilizing extracellular or membrane-proximal complexes, the protein can dampen receptor–ligand signaling throughput. This causal chain—multivalent binding scaffold leading to pathway attenuation—maps to GO:0045746 negative regulation of Notch signaling pathway.
- 04
Cellular placement follows from both the modular extracellular fold suite and the membrane-proximal annotation.
The prealbumin/transthyretin-like and SpaA-like domains are archetypal extracellular folds, and the overall signal-sculpting role requires exposure near the cell surface. Thus, the protein operates at the membrane interface, consistent with GO:0016020 membrane, and aligns with a cell-membrane-associated, secreted/peripheral localization.
- 05
Mechanistically, I hypothesize that the tandem NOMO-like domains assemble a high-avidity platform that captures cell-surface complexes involved in developmental signaling.
By clustering and stabilizing extracellular assemblies, the scaffold attenuates Notch pathway activation—likely by constraining receptor–ligand encounter geometry or by recruiting inhibitory partners. Its ribosome-binding propensity suggests coupling to ER-associated ribosomes, coordinating co-translational folding and secretion of pathway components. Likely interaction partners include membrane-proximal signaling modules and ribosome-associated factors that together tune Notch pathway output and developmental decisions.
Technical details
InterPro entries
- IPR013783 Immunoglobulin-like fold homologous superfamily · 122–226
- IPR013784 Carbohydrate-binding-like fold homologous superfamily · 127–202
- IPR013784 Carbohydrate-binding-like fold homologous superfamily · 329–403
- IPR013784 Carbohydrate-binding-like fold homologous superfamily · 883–954
- IPR008969 Carboxypeptidase-like, regulatory domain superfamily homologous superfamily · 964–1053
- IPR055075 NOMO-like, N-terminal beta-sandwich domain domain · 40–124
- IPR056189 NOMO, third transthyretin-like domain domain · 226–325
- IPR056190 NOMO, fifth transthyretin-like domain domain · 409–498
- IPR056319 NOMO, seventh transthyretin-like domain domain · 592–664
- IPR056187 NOMO, eighth prealbumin-like domain domain · 746–798
- IPR055073 NOMO-like, ninth beta-sandwich domain domain · 799–873
- IPR041033 SpaA-like, prealbumin fold domain subgroup 1 domain · 874–955
- IPR056191 NOMO, C-terminal transthyretin-like domain domain · 1054–1147
- IPR051417 Serine-Aspartate Repeat-Containing family · 44–1191
Sources
- Sequence: UniProt P69849
- Structure: AlphaFold DB (PDB file)
- Domains: InterPro
- Dark protein list: Pharos (Tdark)
Method
BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →